Amount of Lactose Causing Symptoms in Lactose Intolerant People
NCT00395954 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2009-02-16
Summary
The hypothesis underlying this study is that failure to recognise the role of lactose intolerance among patients has led to inappropriate dietary advice and treatment with drugs that contain lactose as a filler. These failures exacerbate symptoms and lead to the unnecessary use of immune suppressant drugs.
This study will identify the threshold at which symptoms of lactose intolerance develop, to provide appropriate advice and treatment in the management of patients.
Conditions
- Lactose Intolerance
Sponsors & Collaborators
-
University Hospitals, Leicester
lead OTHER
Principal Investigators
-
John F Mayberry, DSc MD · University Hospitals, Leicester
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2007-06-30
- Completion
- 2007-06-30
More Related Trials
-
Safety Study of Larazotide Acetate to Treat Celiac Disease.
NCT00386165 ·Status: COMPLETED ·Phase: PHASE1
-
Gluten and (Extra-)Intestinal Symptoms in NCGS
NCT05779358 ·Status: COMPLETED ·Phase: NA
-
Treatment of Egg Allergy in Children Through Oral Desensitization (EGG OIT)
NCT00597558 ·Status: COMPLETED ·Phase: NA
-
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Patients With Non-coeliac Gluten Sensitivity
NCT03798249 ·Status: UNKNOWN ·Phase: NA
-
Endomicroscopy in Patients With Food Allergy: a New Diagnostic Option
NCT01072084 ·Status: COMPLETED
-
Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
NCT02472704 ·Status: COMPLETED ·Phase: NA
-
A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia
NCT03038633 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects
NCT00362856 ·Status: COMPLETED ·Phase: PHASE2
-
Nutrition in Children With Food Allergy
NCT01583907 ·Status: UNKNOWN
-
Microbiota as Potential Target for Food Allergy
NCT02087930 ·Status: UNKNOWN
-
Microbiota and Allergy
NCT04750980 ·Status: COMPLETED
-
Washed Microbiota Transplantation for Food Intolerance
NCT07190183 ·Status: RECRUITING
-
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
NCT01396213 ·Status: COMPLETED ·Phase: PHASE2
-
Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease
NCT03321214 ·Status: COMPLETED ·Phase: NA
-
The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery
NCT02103270 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Immunotherapy in Food Allergy in Finland
NCT02640014 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms
NCT03569007 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
NCT00492960 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Potential Allergenicity of New Soybean Varieties
NCT01950559 ·Status: TERMINATED
-
Study of Tolerance to Oral Peanut
NCT01259804 ·Status: COMPLETED ·Phase: PHASE1
-
The Feasibility of Systemic Reaction After Contact Exposure to the Allergenic Food in Children With Known Food Allergy
NCT05080127 ·Status: UNKNOWN ·Phase: NA
-
Registry of Food Allergy Oral Immunotherapy Treatment
NCT03059589 ·Status: COMPLETED
-
Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy
NCT05695456 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease
NCT00620451 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerance Following Peanut Oral Immunotherapy
NCT01750879 ·Status: COMPLETED ·Phase: PHASE1/PHASE2